Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony.

Foster KG, Fingar DC.

J Biol Chem. 2010 May 7;285(19):14071-7. doi: 10.1074/jbc.R109.094003. Epub 2010 Mar 15. Review.

2.

mTOR signaling: at the crossroads of plasticity, memory and disease.

Hoeffer CA, Klann E.

Trends Neurosci. 2010 Feb;33(2):67-75. doi: 10.1016/j.tins.2009.11.003. Epub 2009 Dec 4. Review.

3.

Common corruption of the mTOR signaling network in human tumors.

Menon S, Manning BD.

Oncogene. 2008 Dec;27 Suppl 2:S43-51. doi: 10.1038/onc.2009.352. Review.

4.

mTOR signaling in cancer cell motility and tumor metastasis.

Zhou H, Huang S.

Crit Rev Eukaryot Gene Expr. 2010;20(1):1-16. Review.

5.

mTOR signaling in autophagy regulation in the kidney.

Inoki K.

Semin Nephrol. 2014 Jan;34(1):2-8. doi: 10.1016/j.semnephrol.2013.11.002. Epub 2013 Nov 21. Review.

6.
7.

Dynamic balancing: DEPTOR tips the scales.

Proud CG.

J Mol Cell Biol. 2009 Dec;1(2):61-3. doi: 10.1093/jmcb/mjp012. Epub 2009 Aug 25.

8.

mTOR signaling in glioblastoma: lessons learned from bench to bedside.

Akhavan D, Cloughesy TF, Mischel PS.

Neuro Oncol. 2010 Aug;12(8):882-9. doi: 10.1093/neuonc/noq052. Epub 2010 May 14. Review.

9.

A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.

Sekulić A, Hudson CC, Homme JL, Yin P, Otterness DM, Karnitz LM, Abraham RT.

Cancer Res. 2000 Jul 1;60(13):3504-13.

10.

mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?

Fernandez D, Perl A.

Discov Med. 2010 Mar;9(46):173-8. Review.

11.

Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity.

Huang S, Shu L, Easton J, Harwood FC, Germain GS, Ichijo H, Houghton PJ.

J Biol Chem. 2004 Aug 27;279(35):36490-6. Epub 2004 Jun 24.

12.

Mammalian TOR signaling to the AGC kinases.

Su B, Jacinto E.

Crit Rev Biochem Mol Biol. 2011 Dec;46(6):527-47. doi: 10.3109/10409238.2011.618113. Epub 2011 Oct 10. Review.

13.

The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.

Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F.

Invest Ophthalmol Vis Sci. 2010 Jan;51(1):421-9. doi: 10.1167/iovs.09-3974. Epub 2009 Aug 6.

PMID:
19661225
14.

The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism.

Powell JD, Delgoffe GM.

Immunity. 2010 Sep 24;33(3):301-11. doi: 10.1016/j.immuni.2010.09.002. Review.

15.

Mammalian target of rapamycin signaling in the podocyte.

Inoki K, Huber TB.

Curr Opin Nephrol Hypertens. 2012 May;21(3):251-7. doi: 10.1097/MNH.0b013e3283520f38. Review.

PMID:
22388550
16.

The multifunctional role of mTOR in innate immunity: implications for transplant immunity.

Säemann MD, Haidinger M, Hecking M, Hörl WH, Weichhart T.

Am J Transplant. 2009 Dec;9(12):2655-61. doi: 10.1111/j.1600-6143.2009.02832.x. Epub 2009 Sep 25. Review.

17.

Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments.

Caccamo A, Majumder S, Richardson A, Strong R, Oddo S.

J Biol Chem. 2010 Apr 23;285(17):13107-20. doi: 10.1074/jbc.M110.100420. Epub 2010 Feb 23.

18.

[mTOR inhibitors].

Oya M.

Nihon Rinsho. 2010 Jun;68(6):1067-71. Review. Japanese.

PMID:
20535957
19.

Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma.

Hansel DE, Platt E, Orloff M, Harwalker J, Sethu S, Hicks JL, De Marzo A, Steinle RE, Hsi ED, Theodorescu D, Ching CB, Eng C.

Am J Pathol. 2010 Jun;176(6):3062-72. doi: 10.2353/ajpath.2010.090872. Epub 2010 Apr 15.

20.

Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks.

Magnuson B, Ekim B, Fingar DC.

Biochem J. 2012 Jan 1;441(1):1-21. doi: 10.1042/BJ20110892. Review.

PMID:
22168436
Items per page

Supplemental Content

Write to the Help Desk